ATMS shows news on their website; they attended Rodman & Renshaw Investment Conference in September. Today's filing showing new institutional owner Michael Vasinkevich (Acumen) 13% https://www.otcmarkets.com/financialReportViewer?symbol=ATMS&id=180565
If you google Michael Vasinkevich, you will find that he is the founding partner of Rodman & Renshaw Capital Group.News all pointing to Rodman & Renshaw Investment. Coincidence ?
Mr. Michael Vasinkevich serves as Senior Managing Director, Vice Chairman and Founding Partner of Rodman & Renshaw Capital Group, Inc., and served as its Senior Managing Director since July 2002.
Artemis Presentation Webcast – Rodman & Renshaw 19th Annual Global Investment Conference Brian M. Culley, CEO of Artemis Therapeutics Inc. (OTCMKTS: ATMS), presents on the company at the Rodman & Renshaw 19th Annual Global Investor Conference.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.